Search

1244447
1240861
1230819
1195994
393884
Final results from M72 AS01E TB Vaccine Trial
The final results from the M72AS01E TB vaccine study have been published in the New England Journal of Medicine. The vaccine demonstrated a 50% efficacy rate in the incidence of lung TB disease in HIV-negative adults, already infected with latent...
Beat TB drama production
Beat TB, a Welcome Trust funded street theater production which raised awareness about tuberculosis (TB) and vaccine research understanding amongst the broader public of the Worcester area. during 2016.
2018 Tb under the Spotlight Science Engagement
The “TB Under the Spotlight Science Engagement” programme was conceptualised and presented by South African Tuberculosis Vaccine Initiative (SATVI) with scientists from the Division of Molecular Biology and Human Genetics at Stellenbosch University...
New multi-functional TB blood test validated
Researchers the South African Tuberculosis Vaccine Initiative (SATVI), the Center for Global Infectious Disease Research(USA) and a large consortium of collaborators have developed a validated a new, simple blood-based test that has the potential to...
Community Engagement
Carina's Choice: SATVI collaborated with UCT Drama Department and Worcester Secondary School in developing this play which was performed by learners from Worcester Secondary School at 8 local high schools reaching approximately 8 000 adolescents in...

News

Tuesday, 20 October 2020
A new algorithm to study millions of receptors that T cells use to recognise pathogens

Scientists from UCT and Stanford Medicine University have developed a new method to compare and find commonalities within millions of T cell receptors (TCR), the receptors used by T cells to recognise pathogens.

Publication Date:
Fri, 08 May 2020 - 17:30
22 April 2010 SATVI Annual Report 2019 available

The 2019 SATVI Annual Report is now available online. 

Publication Date:
Thu, 23 Apr 2020 - 13:30
20 April 2020 Latest Research: Renewing the fight against TB with an old vaccine

Professor Val Mizrahi and Tom Scriba have co-authored a journal article titled "Renewing the Fight Against TB With an Old Vaccine" appearing in the Cell journal. 

Publication Date:
Thu, 23 Apr 2020 - 12:45
7 April 2020 Research: Immune Phenotype and Functionality of Mtb-Specific T-Cells in HIV/TB Co-Infected Patients on Antiretroviral Treatment.

SATVI researchers Professor Tom Scriba, Associate Professor Elisa Nemes, Cheleka Mpande and Tim Reid have co-authored a journal article titled "Immune Phenotype and Functionality of Mtb-Specific T-Cells in HIV/TB Co-Infected Patients on Antiretroviral Treatment" appearing in the Pathogens journal.

Publication Date:
Thu, 16 Apr 2020 - 10:00

Pages